Effects of daidzein and genistein on markers of cardiovascular disease risk among women with impaired glucose regulation: a double-blind, randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Effects of daidzein and genistein on markers of cardiovascular disease risk among women with impaired glucose regulation: a double-blind, randomized, placebo-controlled trial

Published:2021 Issue:17 Volume:12 Page:7997-8006
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Ye Yan-Bin¹^ORCID,He Kai-Yin²,Li Wan-Lin³,Zhuo Shu-Yu¹,Chen Yu-Ming⁴⁵,Lu Wei¹,Wu Shang-Ling¹,Liu Juan⁶,Li Yan-Bing⁶,Zeng Fang-Fang³^ORCID

Affiliation:

1. Department of Clinical Nutrition, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People's Republic of China

2. Department of Nutrition, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, People's Republic of China

3. Department of Epidemiology, School of Medicine, Jinan University, Guangzhou, 510632, People's Republic of China

4. Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China

5. Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China

6. Department of Endocrinology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People's Republic of China

Abstract

Soy protein and soy isoflavones have been suggested to be associated with improved cardiovascular risk factors (e.g., lipid profiles and uric acid (UA)), but few studies have been conducted among women with impaired glucose regulation (IGR).

Funder

Instituto Danone

National Natural Science Foundation of China

Chinese Nutrition Society

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/FO/D1FO00712B

Reference53 articles.

1. The impact of cardiovascular disease on people with diabetes: the potential for prevention